China Continuous Glucose Monitoring Devices Market – Market Insight

Diabetes is one of the most prevalent diseases in the world. As stated by the International Diabetes Federation in November 2019, around 463 million adults in the age group of 20 to 79 years are diagnosed with diabetes in 2019, and it is estimated that the total diabetes population will reach nearly 700 million by 2045 globally. Continuous glucose management devices play a very important role in maintaining and monitoring the glucose equilibrium of the body and the increasing adaptability of these devices, coupled with rising prevalence of diabetes is expected to boost the demand for continuous glucose monitoring devices.

The China continuous glucose monitoring devices market size is estimated to be valued at US$ 78.2 Mn in 2019 and is expected to exhibit a CAGR of 22.8% over the forecast period (2019–2027).

Figure 1. China Continuous Glucose Monitoring Devices Market Share (%), by Component

China Continuous Glucose Monitoring Devices  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Rising incidence of diabetes in China is expected to drive the market growth over the forecast period

According to the International Diabetes Federation’s 2019 report, around 116 million people in between the age group of 20-79 years are suffering from diabetes in China.

Moreover, technological advancements in glucose monitoring devices is expected to propel the market growth during forecast period. For instance, in September 2019, Abbott Laboratories launched its upgraded FreeStyle Libre 14 day Glucose Monitoring device. The FreeStyle Libre 14 day system incorporates a wearable sensor that is placed on the back of the upper arm. The wearer can use their smartphone to get real-time glucose measurement simply by holding it near the sensor. An app on the phone will display current glucose levels, and information on how glucose levels are changing at that moment and trends in glucose levels over the previous eight hours and up to 90 days.

However, high cost of continuous glucose monitoring devices is expected to hinder the market growth. Continuous glucose monitoring devices are more expensive than standard glucose meters as the sensor lifetime is a major factor affecting the cost, inconvenience and user acceptance. Also, health plans, insurance companies, and governments in most countries do not provide reimbursement for continuous glucose monitoring devices, which has led to certain reluctance among patients towards the adoption of these devices which cost around US$ 3,000 per year per patient.

Figure 2. China Continuous Glucose Monitoring Devices Market Share (%), by End User

China Continuous Glucose Monitoring Devices  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Convenience offered by the continuous glucose monitoring devices (CGM) over self-monitoring devices is expected to propel the market growth over the forecast period

The development of continuous glucose monitoring devices marked a remarkable change in diabetes care, as these devices provide real-time information on blood glucose levels less invasively than conventional glucose monitoring devices. Continuous glucose monitoring devices automatically and constantly track blood glucose levels throughout the day, thus providing information that can be analyzed to make informed decisions about managing dietary habits, physical activity, and medication. CGM systems require fewer finger sticks and allows sharing and transfer of data for further analysis.

Moreover, increasing launches of CGM devices is expected to drive the growth of the China continuous glucose monitoring devices market. For instance in January 2019, Ascensia Diabetes Care, a Switzerland-based technology company formed through the merger of Bayer Health’s diabetes division and Panasonic Healthcare, is officially moving into the CGM space through a partnership with Huzhou, China-based Zhejiang POCTech. With this partnership Ascensia launched the branded version of POCTech’s CE-Marked CGM devices in several markets including China. Currently Ascensia, is focused on development of CGM devices for in-house application and company will co-develop a next generation product with POCTech.

Key Players

Major players operating in the China continuous glucose monitoring devices market include Medtronic PLC, Abbott Laboratories, Medtrum Technologies, Inc., Senseonics, Nemaura, STMicroelectronics, NXP Semiconductors, Qualcomm, Taiwan Semiconductor Manufacturing Company Limited, GE Healthcare, Microchip Technology Inc., Texas Instruments Inc., Micron Technology Inc., Renesas Electronics Corporation, and Toshiba Corporation.

Continuous glucose monitoring (CGM) devices provide insights about glucose levels of diabetic patients throughout the day. CGM devices are mostly used by patients with type 1 and type 2 diabetes for better glucose control to improve the health and quality of life. Moreover, the integration of smartphone for easy diabetes management and cloud-based data storage are key features of the currently available CGM devices which have contributed to the drastic adoption of the CGM systems. The CGM devices display a complete picture of glucose trends with a graphical display and customizable alerts to indicate the disturbances in glucose status.

Market Dynamics

The major factors driving growth of the continuous glucose monitoring devices market include rapid technological advancement in CGM devices along with increasing adoption of inorganic growth strategies such as collaborations and agreements to develop novel CGM devices in the market is expected to drive the market growth over the forecast period. For instance, in September 2019, Medtronic Plc. collaborated with Novo Nordisk to provide integrated digital solutions for people with diabetes. Medtronic and Novo Nordisk are collaboratively developing solutions to integrate insulin dosing data from Novo Nordisk’s smart insulin pens with Medtronic’s continuous glucose monitoring (CGM) solutions such as the Guardian Connect system.

Key features of the study:

  • This report provides an in-depth analysis of the China continuous glucose monitoring devices market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the China continuous glucose monitoring devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Medtronic Plc., Abbott Laboratories, Medtrum Technologies, Inc., Senseonics, Nemaura, STMicroelectronics, NXP Semiconductors, Qualcomm, Taiwan Semiconductor Manufacturing Company Limited, GE Healthcare, Microchip Technology Inc., Texas Instruments Inc., Micron Technology Inc., Renesas Electronics Corporation, and Toshiba Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The China continuous glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the China continuous glucose monitoring devices market

Detailed Segmentation:

  • China Continuous Glucose Monitoring Devices Market, By Component:
    • Transmitters
    • Receivers
    • Insulin Pumps
    • Sensors
  • China Continuous Glucose Monitoring Devices Market, By End User:
    • Hospitals & Clinics
    • Homecare Settings
    • Others
  • Company Profiles
    • Medtronic Plc. *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Abbott Laboratories
    • Medtrum Technologies, Inc.
    • Senseonics
    • Nemaura
    • STMicroelectronics
    • NXP Semiconductors
    • Qualcomm
    • Taiwan Semiconductor Manufacturing Company Limited
    • GE Healthcare
    • Microchip Technology Inc.
    • Texas Instruments Inc.
    • Micron Technology Inc.
    • Renesas Electronics Corporation
    • Toshiba Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Component
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Reimbursement Scenario
    • Recent Product Launch
    • PEST Analysis
    • Epidemiology
  4. China Continuous Glucose Monitoring Devices Market, By Component, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Transmitters
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Receivers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Insulin Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Sensors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. China Continuous Glucose Monitoring Devices Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals & Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Homecare settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Medtronic Plc. *
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtrum Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Senseonics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nemaura
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • STMicroelectronics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • NXP Semiconductors
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Qualcomm
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Taiwan Semiconductor Manufacturing Company Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GE Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Microchip Technology Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Texas Instruments Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Micron Technology Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Renesas Electronics Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Toshiba Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
        • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 07 market data tables and 10 figures on "Continuous Glucose Monitoring Devices Market” – China forecast to 2027.